Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs

Abstract This study evaluated the tolerability and efficacy of the topical rho-kinase inhibitor netarsudil for canine primary corneal endothelial degeneration (PCED). Twenty-six eyes of 21 client-owned dogs with PCED were enrolled in a prospective, randomized, vehicle control clinical trial and rece...

Full description

Bibliographic Details

Main Authors:	M. Isabel Casanova, Sangwan Park, Melaney A. Mayes, Karolina Roszak, Michelle Ferneding, Nayeli Echeverria, Morgan A. W. Bowman, Sarah R. Michalak, Monica Ardon, Sydni Wong, Sophie M. Le, Nicole Daley, Brian C. Leonard, Kathryn L. Good, Jennifer Y. Li, Sara M. Thomasy
Format:	Artigo
Language:	Inglês
Published:	Nature Portfolio 2024-03-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-024-56084-4
Tags:	Add Tag No Tags, Be the first to tag this record!